Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: Sensitivity to sequence of injections

Synapse

Volumn 38, Issue 1, 2000, Pages 17-26

  Taber, Matthew T ^a   Kinney, Gene G ^a   Pieschl, Rick L ^a   Yocca, Frank D ^a   Gribkoff, Valentin K ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Electrophysiology; In vitro; In vivo; Microdialysis; Rats; SSRI

Indexed keywords

FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG POTENTIATION; MALE; MICRODIALYSIS; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL;

ACTION POTENTIALS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; EXTRACELLULAR SPACE; FLUOXETINE; MALE; MICRODIALYSIS; NEURONS; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 0033847150     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(200010)38:1<17::AID-SYN3>3.0.CO;2-5     Document Type: Article

References (45)

1. Physiology of midbrain serotonin systems
2. 5-HT(1A) receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram
3. The 5-HT(1A) receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram
4. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
5. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT(1A) antagonists
6. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
7. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei
8. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: A double-blind, placebo-controlled trial
9. Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: Preliminary findings
10. Current advances and trends in the treatment of depression
11. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: An electrophysiological study in the rat brain
12. Calcium-dependent, tetrodotoxin-sensitive stimulation of cortical serotonin release after a tryptophan load
13. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain
14. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT(1A) autoreceptor in vivo
15. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan
16. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats
17. Role of 5-HT(1A) autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies
18. Interaction between a selective 5-HT(1A) receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT
19. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: Studies on the role of 5-HT(1A) autoreceptors and noradrenergic mechanisms
20. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: Mediation by different receptor subtypes
21. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: This effect persists after repeated citalopram treatment
22. A simple perfusion chamber for the study of nervous tissue slices in vitro
23. Serotonin 5-HT(1A) autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: A microdialysis study
24. Raphe 5-HT(1A) autoreceptors, but not postsynaptic 5-HT(1A) receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo
25. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
26. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex
27. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: Role of presynaptic 5-HT(1A) receptors
28. Effect of 5-HT(1A) receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus
29. Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: Implications for endogenous depression
30. Regional differences in the effect of the combined treatment of WAY 100635 and fiuoxetine: An in vivo microdialysis study
31. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain
32. Pindolol augmentation of antidepressant therapy
33. The role of 5-HT(1A) and 5-HT(1B)/1D receptors on the modulation of acute fluoxetine-induced changes in 5-HT: The mechanism of action of Pindolol
34. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
35. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors
36. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum
37. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT(1A) receptor antagonists in the dorsal raphe pathway: Role of somatodendritic autoreceptors
38. Effect of pindolol on the function of pre- and postsynaptic 5-HT(1A) receptors: In vivo microdialysis and electrophysiological studies in the rat brain
39. The 5-HT(1A) antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain
40. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
41. Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450
42. Paroxetine and pindoloh a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency
43. Human cytochromes mediating N-demethylation of fluoxetine in vitro
44. How long should pindolol be associated with paroxetine to improve the antidepressant response?